UroGen Pharma Ltd. - Common Stock (URGN)

CUSIP: M96088105

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
+239,378
SEC-reported price per share
$8.71
Number of holders
82
Value change
+$1,868,931
Number of buys
34
Number of sells
26
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,549,968

Security key

M96088105

Report period

Q1 2022

Institutions

82

Top holders

10

Ownership snapshot

Top reported holders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MENORA MIVTACHIM HOLDINGS...
Disclosed value leader
MENORA MIVTACHIM HOLDINGS...
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $28,078,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MENORA MIVTACHIM HOLDINGS LTD. has the largest disclosed position value at $28.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MENORA MIVTACHIM HOLDINGS LTD.'s linked filing trail.
Disclosed position value Top 5
MENORA MIVTACHIM HOLDINGS LTD. $28.08M
BlackRock Finance, Inc. $16.43M
CREDIT SUISSE AG/ $10.33M
Harel Insurance Investments & Fin... $9.75M
GREAT POINT PARTNERS LLC $8.31M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
13F
—
denominator unverified
$28,078,000
2,952,489 shares
— 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$16,434,000
1,728,094 shares
— 31 Dec 2021
CREDIT SUISSE AG/
13F
Company
13F
—
denominator unverified
$10,326,000
1,085,729 shares
— 31 Dec 2021
Harel Insurance Investments & Financial Services Ltd.
13F
Company
13F
—
denominator unverified
$9,754,000
1,025,675 shares
— 31 Dec 2021
GREAT POINT PARTNERS LLC
13F
Company
13F
—
denominator unverified
$8,306,000
873,424 shares
— 31 Dec 2021
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$8,154,000
857,464 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
82
Shares
14,223,995
Rows available
82
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
82
Q1 2022 holders
82
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .